Biofilm development by clinical strains of non-pigmented rapidly growing mycobacteria

Clinical Microbiology and Infection

Volumn 15, Issue 10, 2009, Pages 931-936

  Martin de Hijas N Z ^a   Garcia Almeida D ^a   Ayala, G ^b   Fernandez Roblas R ^a   Gadea, I ^a   Celdran A ^c   Gomez Barrena E ^a   Esteban, J ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c Department of Surgery ^*  (Spain)

Author keywords

Biofilm; Clinical significance; Microtitre; Motility; Rapidly growing mycobacteria

Indexed keywords

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; CELL MOTILITY; CONTROLLED STUDY; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM MAGERITENSE; MYCOBACTERIUM MUCOGENICUM; MYCOBACTERIUM PEREGRINUM; NONHUMAN; PRIORITY JOURNAL;

CORYNEBACTERINEAE;

EID: 70350596490     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02882.x     Document Type: Article

References (28)

1. Costerton JW. The Biofilm Primer 2007, Berlin, Springer-Verlag
2. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001, 33:1387-1392.
3. Brown-Elliott BA, Wallace RJ. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002, 15:716-746.
4. De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis 2006, 42:1756-1763.
5. Esteban J, Martín-de-Hijas NZ, Fernández AI, Fernández-Roblas R, Gadea I. Epidemiology of infections due to Non-pigmented Rapidly Growing Mycobacteria diagnosed in an urban area. Eur J Clin Microbiol Infect Dis 2008, 27:951-957.
6. Zambrano MM, Kolter R. Mycobacterial biofilms: a greasy way to hold it together. Cell 2005, 123:762-764.
7. Esteban J, Zamora N, Ortiz A, Kinnari TJ. Recent developments in the study of pathogenesis of infections due to non-pigmented rapidly growing mycobacteria. Curr Trends Microbiol 2006, 2:31-39.
8. Bardouniotis E, Ceri H, Olson ME. Biofilm formation and biocide susceptibility testing of Mycobacterium fortuitum and Mycobacterium marinum. Curr Microbiol 2003, 46:28-32.
9. Hall-Stoodley L, Keevil CW, Lappin-Scott H. Mycobacterium fortuitum and Mycobacterium chelonae biofilm formation under high and low nutrient conditions. J Appl Microbiol 1999, 65(Symposium Supplement):60S-69S.
10. Hall-Stoodley L, Lappin-Scott H. Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum. FEMS Microbiol Lett 1998, 168:77-84.
11. Greendyke R, Byrd TF. Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to planktonic bacteria. Antimicrob Agents Chemother 2008, 52:2019-2026.
12. Esteban J, Martin-de-Hijas NZ, Kinnari TJ, Ayala G, Fernandez-Roblas R, Gadea I. Biofilm development by potentially pathogenic non-pigmented rapidly growing mycobacteria. BMC Microbiol 2008, 8:184.
13. Martinez A, Torello S, Kolter R. Sliding motility in mycobacteria. J Bacteriol 1999, 181:7331-7338.
14. Recht J, Kolter R. Glycopeptidolipid acetylation affects sliding motility and biofilm formation in Mycobacterium smegmatis. J Bacteriol 2001, 183:5718-5724.
15. Freeman R, Geier H, Weigel KM, Do J, Ford TE, Cangelosi GA. Roles for cell wall glycopeptidolipid in surface adherence and planktonic dispersal of Mycobacterium avium. Appl Environ Microbiol 2006, 72:7554-7558.
16. Byrd TF, Lyons CR. Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection. Infect Immun 1999, 67:4700-4707.
17. Howard ST, Rhoades E, Recht J. Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. Microbiology 2006, 152:1581-1590.
18. Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993, 31:175-178.
19. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997, 156(2 Pt 2):S1-S25.
20. Esteban J, Fernández-Roblas R, García-Cía JI, Zamora N, Ortiz A. Clinical significance and epidemiology of non-pigmented rapidly growing mycobacteria in a university hospital. J Infect 2007, 54:135-145.
21. von Graevenitz A, Punter Streit V. Failure to recognize rapidly growing mycobacteria in a proficiency testing sample without specific request-a wider diagnostic problem?. Eur J Epidemiol 1998, 14:519-520.
22. Chen JM, German GJ, Alexander DC, Ren H, Tan T, Liu J. Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis. J Bacteriol 2006, 188:633-641.
23. Rose L, Kaufmann SH, Daugelat S. Involvement of Mycobacterium smegmatis undecaprenyl phosphokinase in biofilm and smegma formation. Microbes Infect 2004, 6:965-971.
24. Teng R, Dick T. Isoniazid resistance of exponentially growing Mycobacterium smegmatis biofilm culture. FEMS Microbiol Lett 2003, 227:171-174.
25. Ojha A, Anand M, Bhatt A, Kremer L, Jacobs WR, Hatfull GF. GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell 2005, 123:861-873.
26. Mah TC, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001, 9:34-39.
27. Patel R, Roberts GD, Keating MR, Pay CV. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 1994, 12:263-273.
28. Agustí G, Astola O, Rodríguez-Güell E, Julián E, Luquin M. Surface spreading motility shown by a group of phylogenetically related, rapidly growing pigmented mycobacteria suggests that motility is a common property of mycobacterial species but is restricted to smooth colonies. J Bacteriol 2008, 190:6894-6902.